Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,182,953
-$10,937,262 QoQ
Shares Held
66,353
-81.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jain Global LLC holds $60,325,595 across 44 Biotechnology names. RPRX ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
47,962 | $15,869,186 | |
| 2 | ASND |
Ascendis Pharma A/S
|
17,207 | $3,935,757 | |
| 3 | ARGX |
Argenx SE
|
4,641 | $3,389,090 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
66,353 | $3,182,953 | |
| 5 | MRNA |
Moderna, Inc.
|
62,646 | $3,182,416 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
71,513 | $2,840,496 | |
| 7 | NKTR |
Nektar Therapeutics
|
36,181 | $2,603,222 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
85,178 | $2,359,430 |
All Filings in RPRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,182,953 | 66,353 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,120,215 | 365,430 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,807,012 | 50,153 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $783,012 | 25,153 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||